Navigation Links
Oncolytics Biotech(R) Inc. Announces Second Quarter 2010 Results
Date:7/29/2010

(4,351,974) (4,334,757) (8,493,185) Deduct non-cash items Amortization - intellectual property - 90,375 - Amortization - property and equipment 14,621 16,536 29,506 Stock based compensation 1,399 8,544 2,428 Other non-cash items (415,280) - (46,483) Net changes in non-cash working capital 384,452 (1,414,201) (792,229) ------------------------------------------------------------------------- (4,366,782) (5,633,503) (9,299,963) ------------------------------------------------------------------------- INVESTING ACTIVITIES Capital assets (39,851) - (43,498) Purchase of short-term investments - - - Redemption of short-term investments - 1,925,600 - Investment in BCY LifeSciences Inc. - - - Investment in Transition Therapeutics Inc. - - - ------------------------------------------------------------------------- (39,851) 1,925,600 (43,498) ------------------------------------------------------------------------- FINANCING ACTIVITIES Proceeds from exercise of warrants and stock options 54,000 351,835 54,000 Proceeds from acquisition of private company - 1,800,120 - Proceeds from private placements - - - Proceeds from public offerings - 6,172,819 - -------------------------------------------------------------------------
'/>"/>
SOURCE Oncolytics Biotech Inc.
Copyright©2010 PR Newswire.
All rights reserved

Page: 1 2 3 4 5 6 7 8 9 10 11 12 13

Related biology technology :

1. Oncolytics Biotech(R) Inc. Announces Issuance of 35th U.S. Patent
2. Oncolytics Biotech(R) Inc. To Host Conference Call to Discuss Updated U.K. Phase I/II Trial Head and Neck Cancer Data Being Presented at the ASCO Annual Meeting
3. Oncolytics Biotech(R) Inc. Receives Approval from Belgium FAMHP to Conduct Phase 3 Trial for REOLYSIN(R) in Head and Neck Cancers
4. Oncolytics Biotech(R) Inc. Announces Start of Enrolment in U.S. Phase 2 Pancreatic Cancer Clinical Trial
5. Oncolytics Biotech(R) Inc. Announces Opening of Enrollment in Phase 3 Trial for REOLYSIN(R) in Head and Neck Cancers
6. Oncolytics Biotech(R) Inc. Announces Reovirus Research to be Presented at ASCO Annual Meeting
7. Oncolytics Biotech(R) Inc. Announces Phase I Colorectal Cancer Study
8. Oncolytics Biotech(R) Inc. Announces Publication of Phase I Clinical Trial Results in Clinical Cancer Research
9. Oncolytics Biotech(R) Inc. Announces First Quarter 2010 Results
10. Oncolytics Biotech(R) Inc. Announces Details of 2010 Annual Shareholder Meeting
11. Oncolytics Biotech(R) Inc. Completes Patient Enrollment in Phase I Portion of U.S. Phase I/II Recurrent Malignant Gliomas Clinical Trial
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:7/30/2015)... July 30, 2015   GenoSpace , a ... interpretation and analysis of genomic and other biomedical ... has joined the company as Vice President of ... http://photos.prnewswire.com/prnh/20150730/250931 "GenoSpace partners with ... interpret, analyze and explore complex sets of genomic, ...
(Date:7/30/2015)... ... ... The 2015 Market Research Report on the Global Propanol Industry ... market with a focus on the Chinese situation. Major companies included in the propanol ... Sanofi, Royal Dutch Shell, LG Chem and Zhejiang Xinhua Chemical. , The report provides ...
(Date:7/30/2015)... ... July 30, 2015 , ... Leading ... clinical study of its canine osteoarthritis stem cell product, currently under development for ... KS) and will be marketed in the US by Aratana. This product, termed ...
(Date:7/30/2015)... , Inc. (NASDAQ: SNMX ), a leading company ... commercialize novel flavor ingredients for the food, beverage, and ... second quarter 2015. "Moving into the ... achieve our commercial and financial goals," stated John Poyhonen, ... our last quarterly earnings report, our two partners have ...
Breaking Biology Technology:GenoSpace Introduces Matthew Fischer as Vice President of Sales and Marketing 2Global Propanol Market Technical Data and Manufacturing Analysis 2020 2Global Propanol Market Technical Data and Manufacturing Analysis 2020 3VetStem Biopharma Successfully Completes Large Milestone Efficacy Study for its Flagship Canine Osteoarthritis Stem Cell Product 2VetStem Biopharma Successfully Completes Large Milestone Efficacy Study for its Flagship Canine Osteoarthritis Stem Cell Product 3SENOMYX ANNOUNCES SECOND QUARTER 2015 FINANCIAL RESULTS 2SENOMYX ANNOUNCES SECOND QUARTER 2015 FINANCIAL RESULTS 3SENOMYX ANNOUNCES SECOND QUARTER 2015 FINANCIAL RESULTS 4SENOMYX ANNOUNCES SECOND QUARTER 2015 FINANCIAL RESULTS 5SENOMYX ANNOUNCES SECOND QUARTER 2015 FINANCIAL RESULTS 6SENOMYX ANNOUNCES SECOND QUARTER 2015 FINANCIAL RESULTS 7SENOMYX ANNOUNCES SECOND QUARTER 2015 FINANCIAL RESULTS 8SENOMYX ANNOUNCES SECOND QUARTER 2015 FINANCIAL RESULTS 9
... a world-wide leader in custom genomic and molecular ... position itself as the Next-Generation Sequencing Provider of ... attributed to the company,s ability to respond quickly ... genomics technologies. Building on this success, SeqWright announced ...
... that a new market research report is available in ... 1011 http://www.reportlinker.com/p0358381/Industrial-Biotechnology-China-News-1011.html ... not past." Owing to the monetary easing policy adopted ... affect almost all industries in China, including corn products. ...
... can be used to control the electrical properties ... devices and highly sensitive sensors. This year,s ... into graphene, recognising its potential for many applications ... technology. The UK,s National Physical Laboratory, along with ...
Cached Biology Technology:SeqWright Continues Expansion of Next-Generation Sequencing Capabilities 2Reportlinker Adds Industrial Biotechnology China News 1011 2New research shows how light can control electrical properties of graphene 2
(Date:7/31/2015)... La 10e Conférence internationale sur la ... le BGI du 22 au 25 octobre 2015 ... La conférence célèbre son 10e anniversaire ... est devenue l,une des réunions annuelles mondiales les ... c,est aussi la plus dynamique, la plus enthousiaste ...
(Date:7/30/2015)... July 30, 2015 Cellecta, Inc., a ... function analysis and biomarker discovery, announced the release ... Library targeting all human protein coding genes. CRISPR ... out" a gene,s function. Cellecta,s new Human Whole ... screening tool so that researchers can investigate in ...
(Date:7/21/2015)... 2015 Today, ZTE announced its Android smartphone ... as expected revenues in 2015 that relate to sales of FPC1025 ... of approximately 2,200 MSEK for 2015. Jörgen Lantto, CEO ... manufacturer in China and we are proud ... 5 for Axon , its first ...
Breaking Biology News(10 mins):La 10e International Conference on Genomics (ICG-10) doit s'ouvrir en octobre 2La 10e International Conference on Genomics (ICG-10) doit s'ouvrir en octobre 3CELLECTA, INC. Announces Launch of Human Whole Genome CRISPR Knockout Library 2FPC's Touch Fingerprint Sensor FPC1025 in ZTE's Smartphone Axon 2
... , GALVESTON, Texas Effective immediately, the University of ... for the United States Antarctic Program. UTMB will ... subcontractor for Lockheed Martin,s Antarctic Support Contract. ... Dr. David L. Callender, president of UTMB. "We are ...
... Wyss Institute for Biologically Inspired Engineering at Harvard ... a Cooperative Agreement worth up to $37 million ... to develop an automated instrument that integrates 10 ... the body. This effort builds on the ...
... at the University of Leicester has discovered that South Asians ... higher levels of blood sugar than white Europeans independent of ... of 4,688 white Europeans and 1,352 South Asians was led ... Department of Cardiovascular Sciences, and was published in Diabetes ...
Cached Biology News:University of Texas Medical Branch selected to manage Center for Polar Medical Operations 2Wyss Institute receives up to $37 million from DARPA to integrate organ chips to mimic the human body 2Wyss Institute receives up to $37 million from DARPA to integrate organ chips to mimic the human body 3
Miscellaneous: Versatile stain for staining RNA (bluish-purple), DNA (blue), proteins (red) and acid polysaccharides Assay: ~ 95 % Suitab tst: differential staining of nucleic acids and prote...
Screening test for the detection of Salmonella sp. by means of DNA amplification, subsequent molecular hybridization and detection on a microtitre plate....
... EPICENTREs patented MasterAmp™ 10X PCR ... performance and allows improved sensitivity and ... templates. Using MasterAmp™ PCR Enhancer in ... of DNA melting, increases enzyme?s thermal ...
... simple three step procedure (PCR, Exonuclease III ... in one day. The typical cloning efficiency ... , Features and Benefits: , , Universal ... any expression vector , High Cloning Efficiency ...
Biology Products: